GlobeNewswire Inc.··NaEsperion Secures Fifth Settlement with Generic Drug Maker Over NEXLETOL, NEXLIZET Patents
Esperion secures fifth settlement with generic drugmaker Alkem, extending market exclusivity for cholesterol drugs NEXLETOL and NEXLIZET through April 2040.
SDZNYESPRpatent settlementgeneric drugs